Ovarian Clear Cell Carcinoma: Genomic Characterization, Pathogenesis and Targeted Therapy

被引:2
作者
Xie, Yunkai [1 ]
Kong, Weimin [1 ,2 ]
Luo, Dan [1 ]
Chen, Shuning [1 ]
Zhao, Xiaoling [1 ]
Zhang, He [1 ]
机构
[1] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Beijing Maternal & Child Hlth Care Hosp, Dept Gynecol Oncol, Beijing, Peoples R China
[2] Qi He Lou St, Beijing 100000, Peoples R China
关键词
Endometriosis; ovarian clear cell carcinoma; endometriosis-associated ovarian cancer; oxidative stress; review; GLUTATHIONE-PEROXIDASE; 3; PTEN EXPRESSION; ENDOMETRIOSIS; CANCER; PROGRESSION; ADENOCARCINOMA; PROLIFERATION; INHIBITION; RESISTANCE; MUTATIONS;
D O I
10.21873/anticanres.16515
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ovarian clear cell carcinomas (OCCCs) are a subtype of ovarian epithelial tumors that arise from the malignant transformation of endometriosis (EMs). These tumors have distinctive molecular features, high malignant potential, low sensitivity to conventional chemotherapy, and poor prognosis. The process and mechanism of malignant transformation from EMs to OCCCs remains elusive. Elucidation of the molecular pathogenesis and drug resistance mechanism of OCCCs is essential to guide the clinical management and basic research of this disease. This paper provides a comprehensive review of the mechanisms of malignant transformation, genomic characteristics, drug resistance and targeted therapy of OCCCs. The review aims to provide new insights for the clinical management of advanced OCCCs.
引用
收藏
页码:3401 / 3410
页数:10
相关论文
共 83 条
  • [1] Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression
    Agnani, Deep
    Camacho-Vanegas, Olga
    Camacho, Catalina
    Lele, Shashi
    Odunsi, Kunle
    Cohen, Samantha
    Dottino, Peter
    Martignetti, John A.
    [J]. JOURNAL OF OVARIAN RESEARCH, 2011, 4
  • [2] Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma
    Amano, Tsukuru
    Murakami, Atsushi
    Murakami, Takashi
    Chano, Tokuhiro
    [J]. ANTIOXIDANTS, 2021, 10 (02) : 1 - 15
  • [3] ABC Transporter-Mediated Multidrug-Resistant Cancer
    Amawi, Haneen
    Sim, Hong-May
    Tiwari, Amit K.
    Ambudkar, Suresh V.
    Shukla, Suneet
    [J]. DRUG TRANSPORTERS IN DRUG DISPOSITION, EFFECTS AND TOXICITY, 2019, 1141 : 549 - 580
  • [4] PIK3CA in cancer: The past 30 years
    Arafeh, Rand
    Samuels, Yardena
    [J]. SEMINARS IN CANCER BIOLOGY, 2019, 59 : 36 - 49
  • [5] ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI)
    Banerjee, Susana
    Stewart, James
    Porta, Nuria
    Toms, Christy
    Leary, Alexandra
    Lheureux, Stephanie
    Khalique, Saira
    Tai, Jeremy
    Attygalle, Ayoma
    Vroobel, Katherine
    Lord, Christopher J.
    Natrajan, Rachael
    Bliss, Judith
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (11) : 1471 - 1475
  • [6] Distinguishing the progression of an endometrioma: Benign or malignant?
    Bastu, Ercan
    Onder, Semen
    Demiral, Irem
    Ozsurmeli, Mehmet
    Keskin, Gulsah
    Takmaz, Ozguc
    Ozaltin, Selin
    Gorgen, Husnu
    Gungor, Mete
    Yavuz, Ekrem
    Buyru, Faruk
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2018, 230 : 79 - 84
  • [7] Integrated genomic analyses of ovarian carcinoma
    Bell, D.
    Berchuck, A.
    Birrer, M.
    Chien, J.
    Cramer, D. W.
    Dao, F.
    Dhir, R.
    DiSaia, P.
    Gabra, H.
    Glenn, P.
    Godwin, A. K.
    Gross, J.
    Hartmann, L.
    Huang, M.
    Huntsman, D. G.
    Iacocca, M.
    Imielinski, M.
    Kalloger, S.
    Karlan, B. Y.
    Levine, D. A.
    Mills, G. B.
    Morrison, C.
    Mutch, D.
    Olvera, N.
    Orsulic, S.
    Park, K.
    Petrelli, N.
    Rabeno, B.
    Rader, J. S.
    Sikic, B. I.
    Smith-McCune, K.
    Sood, A. K.
    Bowtell, D.
    Penny, R.
    Testa, J. R.
    Chang, K.
    Dinh, H. H.
    Drummond, J. A.
    Fowler, G.
    Gunaratne, P.
    Hawes, A. C.
    Kovar, C. L.
    Lewis, L. R.
    Morgan, M. B.
    Newsham, I. F.
    Santibanez, J.
    Reid, J. G.
    Trevino, L. R.
    Wu, Y. -Q.
    Wang, M.
    [J]. NATURE, 2011, 474 (7353) : 609 - 615
  • [8] Molecular Classification of Epithelial Ovarian Cancer Based on Methylation Profiling: Evidence for Survival Heterogeneity
    Bodelon, Clara
    Killian, J. Keith
    Sampson, Joshua N.
    Anderson, William F.
    Matsuno, Rayna
    Brinton, Louise A.
    Lissowska, Jolanta
    Anglesio, Michael S.
    Bowtell, David D. L.
    Doherty, Jennifer A.
    Ramus, Susan J.
    Talhouk, Aline
    Sherman, Mark E.
    Wentzensen, Nicolas
    [J]. CLINICAL CANCER RESEARCH, 2019, 25 (19) : 5937 - 5946
  • [9] Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes
    Bolton, Kelly L.
    Chen, Denise
    Fuente, Rosario Corona de la
    Fu, Zhuxuan
    Murali, Rajmohan
    Kobel, Martin
    Tazi, Yanis
    Cunningham, Julie M.
    Chan, Irenaeus C. C.
    Wiley, Brian J.
    Moukarzel, Lea A.
    Winham, Stacey J.
    Armasu, Sebastian M.
    Lester, Jenny
    Elishaev, Esther
    Laslavic, Angela
    Kennedy, Catherine J.
    Piskorz, Anna
    Sekowska, Magdalena
    Brand, Alison H.
    Chiew, Yoke-Eng
    Pharoah, Paul
    Elias, Kevin M.
    Drapkin, Ronny
    Churchman, Michael
    Gourley, Charlie
    DeFazio, Ann
    Karlan, Beth
    Brenton, James D.
    Weigelt, Britta
    Anglesio, Michael S.
    Huntsman, David
    Gayther, Simon
    Konner, Jason
    Modugno, Francesmary
    Lawrenson, Kate
    Goode, Ellen L.
    Papaemmanuil, Elli
    [J]. CLINICAL CANCER RESEARCH, 2022, 28 (22) : 4947 - 4956
  • [10] Glutathione peroxidases
    Brigelius-Flohe, Regina
    Maiorino, Matilde
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2013, 1830 (05): : 3289 - 3303